Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Scientists assembled the largest molecular dataset and used it to uncover new details that may help in diagnosis and treatment.
Lower doses of some cancer drugs might be just as effective and less risky than what is currently prescribed by doctors.
Keytruda can treat women whose endometrial cancer cells have certain characteristics.
High intensity focused ultrasound ablation has the ability to safely and effectively treat this cancer.
A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.
Genomic testing can help customize treatment to target tumors.
The latest drugs approved by the Food and Drug Administration include one for non-small-cell lung cancer and acute myeloid leukemia.
Studies ask whether cancer treatment, such as chemotherapy and immunotherapy, can lead to more severe COVID-19.
Sotorasib and adagrasib target a specific cancer-causing mutation found in those with non-small-cell lung cancer and colorectal cancer.
New targeted therapies and immunotherapies can lead to better treatment outcomes.
After being treated for thyroid cancer with a rare mutation, Susan is helping educate others.
Having diabetes can put a person at greater risk for certain cancers and affect cancer treatment.
Psychologist Seth Axelrod, PhD, has metastatic bone cancer—and a unique set of therapeutic skills that help him live with it.
The nanoparticles led to more cancer-killing immune cells and slowed the growth of melanoma in mice.
Damon Runyon researchers are making an impact through understanding the biology and developing novel treatments.
Study finds that patients with glioblastoma who received corticosteroid dexamethasone had significantly worse overall survival.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.